Pompton Plains, NJ, United States of America

Walter Robert Bishop

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 4.8

ph-index = 4

Forward Citations = 113(Granted Patents)


Company Filing History:


Years Active: 2000-2012

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Walter Robert Bishop: Innovator in Antibody Therapeutics

Introduction

Walter Robert Bishop is a notable inventor based in Pompton Plains, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 5 patents, his work has had a profound impact on medical treatments.

Latest Patents

Among his latest patents, Bishop has developed fully human anti-VEGF antibodies and methods of using them. These antibodies specifically bind to human VEGF, inhibiting its interaction with VEGF-R1 and VEGF-R2, thereby blocking VEGF signaling. This innovation holds promise for treating angiogenesis and related conditions both in vivo and in vitro. Additionally, he has worked on anti-IGFR1 antibody therapeutic combinations, which include a binding composition, such as an anti-IGFR1 antibody, in conjunction with a chemotherapeutic agent. This invention provides methods for treating medical conditions, including cancer.

Career Highlights

Bishop has had a distinguished career, working with prominent companies such as Schering Corporation and Merck Sharp & Dohme Corporation. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the field of therapeutics.

Collaborations

Throughout his career, Bishop has collaborated with notable colleagues, including Joseph J Catino and Ronald J Doll. These partnerships have further enhanced his innovative work and expanded the impact of his inventions.

Conclusion

Walter Robert Bishop is a significant figure in the field of antibody therapeutics, with a focus on innovations that address critical medical challenges. His contributions continue to influence the landscape of biotechnology and therapeutic development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…